Both TRAIL-R1 and -R2 have been found on a wide variety of primary tumor cells and tumor cell lines, making TRAIL-induced apoptosis ideal for therapeutic intervention in a number of malignancies. The gene discussed is TNFRSF10A; the disease is neoplasm.